Approved for Treatment of clinical signs of PPID (equine Cushing's disease) in horses. Stimulates dopamine receptors in the pituitary gland, suppressing excessive ACTH secretion from the pars intermedia. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.
Loading full data from Know Your Drugs Institute…